Pharmaceutical companies rely on the knowledge and expertise of healthcare professionals for purposes such as scientific discussions, clinical trial design, new product development, and information and promotion of new treatments.  All such interactions are subject to strict legal and regulatory requirements in most jurisdictions around the world.

DLA Piper’s global Life Sciences team have recently updated our interactive comparison site on Engaging with Healthcare Professionals. The updated guide covers 35 jurisdictions around the world and provides an overview of the global compliance requirements and restrictions applying to both pharmaceutical and now featuring medical device companies wishing to interact with healthcare professionals.

To access the newly updated guide, click here.